Skip to main content
Premium Trial:

Request an Annual Quote

New Products: Boreal Genomics's OnTarget Allele Enrichment

Premium

Boreal Genomics has launched an early access program for its OnTarget Allele Enrichment System, which depletes wild-type alleles to improve detection of known and unknown rare cancer mutations.

The system enables researchers to enrich rare cancer mutations down to 0.01 percent frequency from plasma, frozen, or formalin-fixed paraffin-embedded samples in less than two hours, according to the company.

The Scan

Push Toward Approval

The Wall Street Journal reports the US Food and Drug Administration is under pressure to grant full approval to SARS-CoV-2 vaccines.

Deer Exposure

About 40 percent of deer in a handful of US states carry antibodies to SARS-CoV-2, according to Nature News.

Millions But Not Enough

NPR reports the US is set to send 110 million SARS-CoV-2 vaccine doses abroad, but that billions are needed.

PNAS Papers on CRISPR-Edited Cancer Models, Multiple Sclerosis Neuroinflammation, Parasitic Wasps

In PNAS this week: gene-editing approach for developing cancer models, role of extracellular proteins in multiple sclerosis, and more.